This paper had been presented for promotion at the University of Khartoum. To get the full text please contact the other at abumalaz2002@gmail.comThe objective of this study was to determine the seroprevalence of hepatitis B virus (HBV) and hepatitis C virus (HCV) infections and the possible risk factors among blood donors in Nyala, South Dar Fur State of western Sudan, which has never been studied before. A total of 400 male blood donors were tested for the detection of HBsAg and anti-HCV antibodies, (6.25%) were found reactive for HBsAg and (0.65%) were reactive for anti-HCV antibodies. The highest seroprevalence (30.8%) was found in those between 19-24 and 37-42 years for HBsAg, whereas it was (50%) in those between 31-36 years fo...
The prevalence of Hepatitis B and C infection varies between different regions of Sudan according to...
Background: In our population, hepatitis B and C has been increasing. Due to these viral infections,...
Background: Thalassemia major patients are managed by regular blood transfusions and chelation thera...
The objective of this study was to determine the seroprevalence of hepatitis B virus (HBV) and hepat...
Abstract The objective of this study was to determine the seroprevalence of hepatitis B virus (HBV) ...
Hatim MY MudawiDepartment of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartou...
Background: Hepatitis B virus is a DNA virus belonging to the Hepadnaviridae family attacking the li...
Objective: The main purpose of this study was to find out the seroprevalence of HBsAg and anti HCV i...
In Sudan, the incidence of hepatocellular carcinoma (HCC) is high and increasing. Hepatitis B virus ...
Hepatitis C is a blood borne liver disease caused by hepatitis C virus (HCV). First identified in 1...
Background: Hepatitis B, C and HIV infections and their impact forms one of the major health problem...
Copyright © 2014 Jafar Khan et al. This is an open access article distributed under the Creative Com...
Aim: This is a cross-sectional study to determine the prevalence and risk factors for transmission ...
Background: Hepatitis B virus (HBV) is the major cause of chronic hepatitis, cirrhosis, and hepatoce...
Hepatitis B virus (HBV) is a major cause of liver disease worldwide. Both acute and chronic HBV infe...
The prevalence of Hepatitis B and C infection varies between different regions of Sudan according to...
Background: In our population, hepatitis B and C has been increasing. Due to these viral infections,...
Background: Thalassemia major patients are managed by regular blood transfusions and chelation thera...
The objective of this study was to determine the seroprevalence of hepatitis B virus (HBV) and hepat...
Abstract The objective of this study was to determine the seroprevalence of hepatitis B virus (HBV) ...
Hatim MY MudawiDepartment of Internal Medicine, Faculty of Medicine, University of Khartoum, Khartou...
Background: Hepatitis B virus is a DNA virus belonging to the Hepadnaviridae family attacking the li...
Objective: The main purpose of this study was to find out the seroprevalence of HBsAg and anti HCV i...
In Sudan, the incidence of hepatocellular carcinoma (HCC) is high and increasing. Hepatitis B virus ...
Hepatitis C is a blood borne liver disease caused by hepatitis C virus (HCV). First identified in 1...
Background: Hepatitis B, C and HIV infections and their impact forms one of the major health problem...
Copyright © 2014 Jafar Khan et al. This is an open access article distributed under the Creative Com...
Aim: This is a cross-sectional study to determine the prevalence and risk factors for transmission ...
Background: Hepatitis B virus (HBV) is the major cause of chronic hepatitis, cirrhosis, and hepatoce...
Hepatitis B virus (HBV) is a major cause of liver disease worldwide. Both acute and chronic HBV infe...
The prevalence of Hepatitis B and C infection varies between different regions of Sudan according to...
Background: In our population, hepatitis B and C has been increasing. Due to these viral infections,...
Background: Thalassemia major patients are managed by regular blood transfusions and chelation thera...